Back to articles
Comparative guide · 5 min read

Hibiscus vs Pomegranate for blood pressure — two polyphenol-rich plants

Updated 2026-05-13 · Reviewed by SupplementScore editors · No sponsorships

Both have reasonable meta-analytic evidence for modest systolic and diastolic BP reductions — on the order of 5–7 mmHg systolic in pre-hypertensive and stage 1 hypertensive adults. Neither is a substitute for evidence-based first-line antihypertensives in established stage 2 hypertension. Hibiscus is the cheaper, lower-calorie, easier-to-dose option (3 cups of tea per day). Pomegranate has somewhat stronger evidence on lipids, endothelial function, and possibly carotid intima-media thickness — but most of the BP trials used pomegranate juice (not extract), which adds 100–150 calories per day if consumed daily.

Quick verdict

GoalBetter choiceWhy
Modest BP reduction in prehypertension / stage 1TieBoth produce ~5–7 mmHg systolic reduction in meta-analysis.
Low-calorie optionHibiscusTea has negligible calories; pomegranate juice is sugar-heavy.
Endothelial function / FMDPomegranateTrial evidence for flow-mediated dilation improvement; broader CV mechanism story.
Lipid profile improvementPomegranateSmall but consistent LDL and oxidised-LDL improvements in trials.
Carotid IMT progressionPomegranate (limited)One small longer-term trial (Aviram et al 2004) showed regression; not replicated at scale.
CostHibiscus (much cheaper)Bulk hibiscus tea is one of the cheapest BP supplements; pomegranate extracts add up.

How they actually work

Hibiscus — anthocyanins and ACE inhibition

Hibiscus sabdariffa contains anthocyanins, hibiscus acid (a hydroxycitric acid derivative), and other polyphenols. Mechanistic work suggests mild ACE-inhibitor activity, diuretic effect, and endothelial relaxation. The clinical signal is most consistent at 2–3 cups of strong hibiscus tea (1.25 g dried calyx steeped in 240 mL boiling water for ~10 min, taken three times daily) — this is the dose used in the McKay 2010 trial that produced ~7 mmHg systolic reduction at six weeks.

Pomegranate — punicalagins and ellagic acid

Pomegranate juice and extract are rich in punicalagins (hydrolysable ellagitannins) and free ellagic acid. The metabolic story includes anti-oxidative effects on LDL, NO-mediated endothelial relaxation, and ACE-inhibitor activity (less potent than ACEi medications). The BP signal is consistent across short-term trials using either standardised juice (240 mL/day) or capsule extracts standardised to punicalagin content.

BP effect size — both modest

Hibiscus meta-analyses show approximately 5–8 mmHg systolic and 3–5 mmHg diastolic reductions in mildly hypertensive adults. Pomegranate meta-analyses show similar magnitudes (5–7 mmHg systolic). Neither approaches the effect of an ACEi, ARB, thiazide, or CCB at standard doses (10–15 mmHg systolic).

What's actually in the product matters

Hibiscus tea is straightforward: dried calyx. Quality and freshness affect anthocyanin content but most consumer hibiscus is reasonable.

Pomegranate is more variable. "Pomegranate juice" should be 100% juice (not "pomegranate flavoured" cocktails with added sugar). Extracts vary widely in punicalagin standardisation; brands that publish punicalagin content (typically 30–40%) are preferable. Many cheap "pomegranate extract" supplements are under-dosed.

Side effects and interactions

Hibiscus: well-tolerated. Modest BP-lowering can add to antihypertensive medication effect — monitor and adjust. May modestly reduce serum potassium at high intake. Pregnancy: avoid daily medicinal-dose hibiscus tea — traditional emmenagogue use; animal models show fetal/uterine effects.

Pomegranate: well-tolerated. Like grapefruit, pomegranate juice can inhibit CYP3A4 in some users — clinically significant interactions reported with statins, calcium channel blockers, and warfarin. Coordinate with prescriber if on these. Juice form adds calories and sugar — consider unsweetened or capsule alternatives for diabetics.

Practical rule. For prehypertension or stage 1 hypertension as an adjunct to lifestyle (DASH-style diet, sodium reduction, weight loss, exercise), either is reasonable. Hibiscus 3 cups/day is the cheaper, lower-calorie, simpler choice. Pomegranate extract (standardised to punicalagin content, 250–500 mg/day) is reasonable if the broader CV mechanism story (lipids, endothelial function) is also a priority. Neither replaces first-line antihypertensives in established stage 2 hypertension.

Combining them

The two are reasonable to combine if budget allows; no trial has tested the combination systematically. The additional effect over either alone is probably small.

Dose, form, and timing

Hibiscus: 1.25 g dried calyx steeped in 240 mL boiling water for 10 min, three times daily. Or hibiscus extract 250 mg twice daily. Allow 2–6 weeks for full BP effect. Drink the tea (don't discard the calyx) for best anthocyanin extraction.

Pomegranate: 240 mL 100%-juice daily, or capsule extract standardised to punicalagin/ellagic acid content at 250–500 mg/day. Take with food to reduce GI effects. Allow 2–6 weeks for full effect.

Who should pick each

Pick hibiscus if: lowest cost, lowest calorie, you enjoy tart tea, no concerns about emmenagogue effects (i.e., not pregnant).

Pick pomegranate if: lipids and endothelial function are also priorities, you have no statin/CCB/warfarin prescription where CYP3A4 inhibition would matter, you can absorb the higher cost.

What we'd actually buy

For most users with prehypertension targeting an adjunct to lifestyle: bulk dried hibiscus calyx, brewed 3x daily, for 8 weeks with home BP monitoring. Reassess at 8 weeks; if effect is meaningful and tolerated, continue. Cost: $5–10/month. Always combined with DASH-style diet, sodium reduction (target <1500–2300 mg/day), weight loss if BMI>27, regular aerobic activity, and reduced alcohol.

Sources

Read more: